KEVIN OCONNOR Insider Trading $AMRI ALBANY MOLECULAR RESEARCH INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for KEVIN OCONNOR.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of KEVIN OCONNOR. KEVIN OCONNOR is Director in ALBANY MOLECULAR RESEARCH INC ($AMRI).

KEVIN OCONNOR in ALBANY MOLECULAR RESEARCH INC

Trading Symbol: AMRI
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of KEVIN OCONNOR: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 05 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of KEVIN OCONNOR in ALBANY MOLECULAR RESEARCH INC

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD18.419,358172,2810
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD15.776,540103,1360
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD17.056,881117,3210
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD10.437,20175,1060
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD5.9912,36774,0780
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD2.5910,00025,9000
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD5.2810,00052,8000
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD6.1510,00061,5000
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD8.8110,00088,1000
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD9.195,00045,9500
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseD13.545,00067,7000
Sep 05 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorSellD21.7558,2751,267,481058.3 K to 0 (-100.00 %)
May 26 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseM14.475,00072,3500
May 26 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyM14.475,00072,35058,27553.3 K to 58.3 K (+9.39 %)
Feb 10 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA18.419,358172,2819,358
Feb 10 2017AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA0.003,802053,27549.5 K to 53.3 K (+7.68 %)
Jun 16 2016AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA14.821,51822,49749,47348 K to 49.5 K (+3.17 %)
Jun 01 2016AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseM10.375,00051,8500
Jun 01 2016AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorSellS14.415,00072,05047,95553 K to 48 K (-9.44 %)
Jun 01 2016AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyM10.375,00051,85052,95548 K to 53 K (+10.43 %)
Feb 08 2016AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA15.776,540103,1366,540
Feb 08 2016AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA15.772,85445,00847,95545.1 K to 48 K (+6.33 %)
Jun 15 2015AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA19.982,25244,99545,10142.8 K to 45.1 K (+5.26 %)
Mar 13 2015AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseM11.855,00059,2500
Mar 13 2015AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorSellS18.225,00091,10042,84947.8 K to 42.8 K (-10.45 %)
Mar 13 2015AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyM11.855,00059,25047,84942.8 K to 47.8 K (+11.67 %)
Mar 04 2015AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA17.056,881117,3216,881
Mar 04 2015AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA17.052,63944,99542,84940.2 K to 42.8 K (+6.56 %)
Feb 28 2014AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseM12.855,00064,2500
Feb 28 2014AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyM12.855,00064,25040,21035.2 K to 40.2 K (+14.20 %)
Feb 06 2014AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA10.437,20175,1067,201
Feb 06 2014AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA10.433,35635,00335,21031.9 K to 35.2 K (+10.54 %)
Jun 06 2013AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA10.461,43415,00031,85430.4 K to 31.9 K (+4.71 %)
Feb 04 2013AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA5.9912,36774,07812,367
Feb 04 2013AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA5.995,84335,00030,42024.6 K to 30.4 K (+23.77 %)
Jun 14 2012AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA2.5910,00025,90010,000
Jun 07 2012AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA2.416,22415,00024,57718.4 K to 24.6 K (+33.91 %)
Jun 09 2011AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA5.2810,00052,80010,000
Jun 03 2011AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA5.143,89120,00018,35314.5 K to 18.4 K (+26.90 %)
Jun 04 2010AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA6.1510,00061,50010,000
Jun 04 2010AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA6.152,43915,00014,46212 K to 14.5 K (+20.29 %)
Jun 04 2009AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA8.8110,00088,10010,000
Jun 04 2009AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA8.811,70214,99512,02310.3 K to 12 K (+16.49 %)
Nov 21 2008AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA9.191,66715,3205,000
Nov 21 2008AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA9.191,66615,3113,333
Nov 21 2008AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA9.191,66715,3201,667
Jun 13 2008AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA13.541,66722,5715,000
Jun 13 2008AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA13.541,66622,5583,333
Jun 13 2008AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA13.541,66722,5711,667
Nov 21 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyP12.817109,09510,3219.6 K to 10.3 K (+7.39 %)
Nov 21 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyP12.794836,1789,6119.1 K to 9.6 K (+5.29 %)
Nov 21 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyP12.581,02512,8959,1288.1 K to 9.1 K (+12.65 %)
Jun 06 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA14.471,66724,1215,000
Jun 06 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA14.471,66624,1073,333
Jun 06 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA14.471,66724,1211,667
Jun 06 2007AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA14.471,03715,0058,1037.1 K to 8.1 K (+14.68 %)
Jul 19 2006AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA10.371,66717,2875,000
Jul 19 2006AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA10.371,66617,2763,333
Jul 19 2006AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA10.371,66717,2871,667
Jun 02 2006AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorGrantA10.379649,9976,5845.6 K to 6.6 K (+17.15 %)
May 20 2005AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA11.851,66719,7545,000
May 20 2005AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA11.851,66619,7423,333
May 20 2005AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA11.851,66719,7541,667
May 20 2005AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyP11.851,68719,9915,6203.9 K to 5.6 K (+42.89 %)
Jun 10 2004AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorBuyP12.857789,9973,9333.2 K to 3.9 K (+24.66 %)
May 21 2004AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA12.851,66621,4085,000
May 21 2004AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA12.851,66721,4210
May 21 2004AMRIALBANY MOLECULAR R ...OCONNOR KEVINDirectorOption ExerciseA12.851,66721,4210

Page:   1